Table: Kobayashi Pharmaceutical -Q1 group results

Kobayashi Pharmaceutical Co

08/05/2026 07:32

May 8 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2026        Mar 31, 2025     Dec 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             33.67               32.61           173.00    
                 (+3.2 pct)          (-10.6 pct)      (+4.4 pct)  
  Operating          1.35                2.54            12.50    
                 (-46.7 pct)         (-49.6 pct)      (-16.2 pct) 
  Recurring          1.67                2.40            13.00    
                 (-30.4 pct)         (-56.0 pct)      (-23.5 pct) 
  Net                1.04                1.62            10.00    
                 (-36.2 pct)         (+66.5 pct)     (+173.5 pct) 
  EPS             13.95 yen           21.86 yen       134.52 yen  
  Ann Div                            104.00 yen       106.00 yen  
  -Q2 div                             44.00 yen        45.00 yen  
  -Q4 div                             60.00 yen        61.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T